:sharpen(level=0):output(format=jpeg)/up/3/default/2025-12/Jane-Knosgaard.png "Jane Knøsgaard")
:sharpen(level=0):output(format=jpeg)/up/3/default/2026-01/LMSXDuraphatX1920x1080XX1X-2.png "Duraphat lægemidler - evidens og anvendelse")
Patienter i din klinik kan være i øget risiko for caries. Det er vigtigt at lave en struktureret risikovurdering samt igangsætte individuel cariesforebyggende behandling. Patienter med høj risikoprofil for caries har brug for ekstra fluorid. Se denne korte gennemgang af evidensen bag Duraphat lægemidler samt information omkring anvendelse.
Learning objectives
- Caries risikovurdering
- Evidens bag Duraphat lægemiddel
- Korrekt anvendelse af Duraphat lægemiddel
Downloadable resources
- Patient-centreret 4-trins guide
En struktureret guide designet som hjælp til risikovurdering og planlægning af cariesbehandling med højfl uoridavailable after course completion
This content is intended to promote understanding and knowledge about general oral health topics. The content was developed by and represents the views and opinion of the presenter. It is not intended to be a substitute for professional advice, diagnosis or treatment, and may not have been reviewed by nor necessarily represent the views of Colgate-Palmolive or its affiliates.
Trainer
Jane Knøsgaard Oral Health Liaison Specialist
More courses with Jane Knøsgaard Oral Health Liaison SpecialistOral Health Liaison Specialist at Colgate Professional Oral Care.
Pharmaconomist and registered pharmaceutical representative at LIF.
:sharpen(level=0):output(format=jpeg)/up/3/default/2025-12/LMSvarnish-2.jpg "Sådan påfører du Duraphat 22,6 mg/ml dentalsuspension")
